Yi Chen

Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study

Guo‐Ming Shi, Xiaoyong Huang, Dong Wu et al. · Signal Transduction and Targeted Therapy · 2023 · 136 citations · Full text

Cholangiocarcinoma therapy with nanoparticles that combine downregulation of MicroRNA-210 with inhibition of cancer cell invasiveness

Ying Xie, Yazhe Wang, Jing Li et al. · Theranostics · 2018 · 44 citations · Full text

CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma

Xiaojun Guo, Jia‐Cheng Lu, Haiying Zeng et al. · Frontiers in Immunology · 2021 · 39 citations · Full text

Gemox chemotherapy in combination with anti-PD1 antibody toripalimab and lenvatinib as first-line treatment for advanced intrahepatic cholangiocarcinoma: A phase 2 clinical trial.

Zhou Jian, Jia Fan, Guo‐Ming Shi et al. · Journal of Clinical Oncology · 2021 · 28 citations

Pathology, Pharmacotherapy, Gemox Chemotherapy +16

The clinical implications and molecular features of intrahepatic cholangiocarcinoma with perineural invasion

Xian‐Long Meng, Jia‐Cheng Lu, Haiying Zeng et al. · Hepatology International · 2022 · 27 citations · Full text